comprehensive -WSS

comprehensive

author：fashion 2025-10-02 01:07:47 - browse：5

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Stem cell treatment guidelines are released by FDA

hotspot

WSS

A clever new way to fix Medicaid and graduate medical education

HPV cancer vaccine study demonstrates efficacy

Abortion clinic in Cancun will cater to Americans

Illumina names Agilent executive as new CEO

Covid hospitalizations on the rise, Humana says

MoonLake credibility takes another hit with mid

hotspot

comprehensive

Wikipedia

Medical records are filled with copy

What American doctors can learn from their Israeli counterparts

United colonoscopy coverage change 'may cost lives,' doctors say

FDA approves potent Eli Lilly obesity drug, Zepbound

Bright Health sells Medicare Advantage business to Molina

Crinetics acromegaly drug succeeds in late

Guidelines to prevent youth baseball injuries need more muscle

A rare thyroid diagnosis led to unexpected, all

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How to fix cancer clinical trials' diversity problem

hotspot

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Study: New antibiotic targets gonorrhea as well as last existing drug

NIH nominee Bertagnolli will get October confirmation hearing

Ethical issues complicate the benefits of medical crowdfunding

The Sacklers, horror, and ‘The Fall of the House of Usher’

A new House health package & hospitals’ new site

hotspot

hotspot

hotspot

Wikipedia